Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Subcellular Optogenetic Stimulation for Activity-Dependent Myelination of Axons in a Novel Microfluidic Compartmentalized Platform.
Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes.
Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery.
Poster 348 Biospy-Confirmed Neurosarcoidosis Manifesting as a Non-Compressive Myelopathy with Transverse Myelitis and Normal ACE Level: A Case Study.
Inadequate outcome measures are the biggest impediment to successful clinical trials in progressive MS - NO.
Patient Management Problem.
Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology.
Interferons and inflammasomes: Cooperation and counterregulation in disease.
Assessment of brain metabolite correlates of AAV-mediated overexpression of human alpha-synuclein in cortical neurons by in vivo(1) H-MR spectroscopy at 9.4 T.
Parkinson's disease and the Stroop color word test: processing speed and interference algorithms.
Findings of Optical Coherence Tomography of Retinal Nerve Fiber Layer in Two Common Types of Multiple Sclerosis.
Classroom demonstration of the visual effects of eye diseases.
SOX10 Regulates an Alternative Promoter at the Charcot-Marie-Tooth Disease Locus MTMR2.
MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b.
Serial Diffusion Tensor Imaging of the Optic Radiations after Acute Optic Neuritis.
A case of severe chronic inflammatory demyelinating polyradiculoneuropathy with monoclonal gammopathy of undetermined significance with alternating immunoglobulin class to IgM from IgA.
Rituximab for treating multiple sclerosis: Off-label but on target.
20/40 or Better Visual Acuity After Optic Neuritis: Not as Good as We Once Thought?
The value of histopathological diagnosis in the elderly patients with granulomatous dermatoses. Case series.
Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system.
Toll-like receptor (TLR)7 and TLR9 agonists enhance interferon (IFN) beta-1a's immunoregulatory effects on B cells in patients with relapsing-remitting multiple sclerosis (RRMS).
Anti-hsp60 antibody responses based on Helicobacter pylori in patients with multiple sclerosis: (ir)Relevance to disease pathogenesis.
Generation of Human Induced Pluripotent Stem Cell-Derived Bona Fide Neural Stem Cells for Ex Vivo Gene Therapy of Metachromatic Leukodystrophy.
The functional performance status during weekdays and weekends in persons with multiple sclerosis.
Cognitive impairment and magnetic resonance imaging correlates in primary progressive multiple sclerosis.
Pages
« first
‹ previous
…
802
803
804
805
806
807
808
809
810
…
next ›
last »